What is the price-to-earnings ratio of Pfizer?
The price-earnings ratio of Pfizer is currently 2.44.
Pfizer P/S 2024
Pfizer P/S
2.44
Pfizer Dividend yield
7.91 %
Ticker
PFE
ISIN
US7170811035
WKN
852009
As of Apr 16, 2024, Pfizer's P/S ratio stood at 2.44, a -34.23% change from the 3.71 P/S ratio recorded in the previous year.
The Pfizer P/S history
Pfizer Aktienanalyse
What does Pfizer do?
Pfizer Inc, one of the world's largest and most well-known pharmaceutical companies, has made significant advancements in the medical industry throughout its approximately 170-year history. The company is headquartered in New York City and has offices in over 150 countries. Pfizer was founded in 1849 by two cousins, Charles Pfizer and Charles Erhart, who opened their first factory in Brooklyn to produce pure crystalline chinasalt. They later expanded their business and began synthesizing chemical compounds, leading them to enter the pharmaceutical industry. In the following years, Pfizer made some significant discoveries, including the synthesis of antibiotics such as penicillin and terramycin. In the 1990s, the company expanded its portfolio and became a leading provider of prescription drugs, immunological medications, and animal health products. Today, the company focuses on three core areas: innovative health products, patented medications, and generic products. Pfizer invests millions of dollars in research and development of new and innovative treatment options, including cancer drugs, therapies for neurological disorders, cardiovascular diseases, and immunology products. Another important aspect of Pfizer's business model is its partnerships with other companies and organizations. The company works closely with universities, research institutions, governments, and other companies to form partnerships that allow for collaborative development of new products. Some of Pfizer's most well-known products include Viagra, Lipitor, Celebrex, Zoloft, and Lyrica. Viagra is used to treat erectile dysfunction in men. Lipitor is a cholesterol-lowering medication that reduces the risk of cardiovascular diseases. Celebrex is an anti-inflammatory medication used to treat pain and inflammation. Zoloft is an antidepressant used to treat various mental disorders. Lyrica is a prescription medication used to treat pain and seizures. In recent years, Pfizer has also taken a leading role in the development of vaccines against COVID-19, collaborating with the German company BioNTech to develop a promising vaccine candidate. The vaccine provides protection against the virus, particularly against severe illness. Over the years, the company has faced concerns regarding the use of medications, such as the scandal surrounding the pain reliever Vioxx, which was withdrawn in 2004 after being associated with an increased risk of cardiovascular diseases. Pfizer has since strengthened its research and development standards and partnerships to ensure the safety and efficacy of its products. In summary, Pfizer is a global player in the pharmaceutical industry. The company heavily invests in research and development of new products to provide innovative treatment options, secures patents, and simultaneously keeps its portfolio up-to-date with generic products to remain competitive in the industry. The company will continue to contribute to improving healthcare worldwide by developing lifesaving medications and vaccines that enable people to lead better lives. Pfizer ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding Pfizer's P/S Ratio
Pfizer's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing Pfizer's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating Pfizer's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in Pfizer’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about Pfizer Stock
How has the price-earnings ratio of Pfizer changed compared to last year?
The price-to-earnings ratio of Pfizer has increased by -34.23% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Pfizer high compared to other companies?
Yes, the price-to-earnings ratio of Pfizer is high compared to other companies.
How does an increase in the price-earnings ratio of Pfizer affect the company?
An increase in the price-earnings ratio of Pfizer would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Pfizer affect the company?
A decrease in the price-earnings ratio of Pfizer would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Pfizer?
Some factors that influence the price-earnings ratio of Pfizer are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Pfizer pay?
Over the past 12 months, Pfizer paid a dividend of 2.05 USD . This corresponds to a dividend yield of about 7.91 %. For the coming 12 months, Pfizer is expected to pay a dividend of 2.45 USD.
What is the dividend yield of Pfizer?
The current dividend yield of Pfizer is 7.91 %.
When does Pfizer pay dividends?
Pfizer pays a quarterly dividend. This is distributed in the months of August, December, December, February.
How secure is the dividend of Pfizer?
Pfizer paid dividends every year for the past 26 years.
What is the dividend of Pfizer?
For the upcoming 12 months, dividends amounting to 2.45 USD are expected. This corresponds to a dividend yield of 9.44 %.
In which sector is Pfizer located?
Pfizer is assigned to the 'Health' sector.
Wann musste ich die Aktien von Pfizer kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Pfizer from 3/1/2024 amounting to 0.42 USD, you needed to have the stock in your portfolio before the ex-date on 1/25/2024.
When did Pfizer pay the last dividend?
The last dividend was paid out on 3/1/2024.
What was the dividend of Pfizer in the year 2023?
In the year 2023, Pfizer distributed 1.6 USD as dividends.
In which currency does Pfizer pay out the dividend?
The dividends of Pfizer are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Pfizer stock can be added to a savings plan with the following providers: Trade Republic, ING, Scalable Capital and Consorsbank
Andere Kennzahlen von Pfizer
Our stock analysis for Pfizer Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Pfizer Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
